Glycos to make isoprene from bacteria in Malaysia

ERJ staff report (DS)

Houston, Texas - Glycos Biotechnologies, Inc. has agreed with Malaysian Bio-XCell for the establishment of the Company's industrial biochemical plant and biotechnology R&D facility in Malaysia. The company plans to focus much of its initial research and development efforts on creating isoprene to support Malaysia's rubber industry.

The Ceremony was held in conjunction with the BioMalaysia 2010 Exhibition and Conference taking place November 1st - 3rd in Kuala Lumpur, Malaysia.

“For Malaysia, isoprene is a strategic product because of the large domestic latex industry and where we plan to focus much of our R&D efforts,” said Richard Cilento, Chief Executive Officer of Glycos Biotechnologies. “With construction underway, our long-term strategy includes further expansion in Malaysian and across Southeast Asia forming joint venture partnerships with existing petrochemical, oleochemical, and biofuel producers and to partner with end market players in the development of advanced biochemicals. There are great opportunities in Malaysia for our microbial platform and sustainable chemical processes and we look forward to the future possibilities.”

This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.

Press release from Glycos